Pawlak CR - Search Results

1

Does Acamprosate Really Produce its Anti-Relapse Effects via Calcium? No Support from the PREDICT Study in Human Alcoholics.

Mann K, Hoffmann S, Pawlak CR. Mann K, et al. Among authors: pawlak cr. Neuropsychopharmacology. 2016 Feb;41(3):659-60. doi: 10.1038/npp.2015.175. Neuropsychopharmacology. 2016. PMID: 26742860 Free PMC article. No abstract available.

2

Cue-induced alcohol-seeking behaviour is reduced by disrupting the reconsolidation of alcohol-related memories.

von der Goltz C, Vengeliene V, Bilbao A, Perreau-Lenz S, Pawlak CR, Kiefer F, Spanagel R. von der Goltz C, et al. Among authors: pawlak cr. Psychopharmacology (Berl). 2009 Aug;205(3):389-97. doi: 10.1007/s00213-009-1544-1. Epub 2009 May 6. Psychopharmacology (Berl). 2009. PMID: 19418040

3

Potential of D-cycloserine in the treatment of behavioral and neuroinflammatory disorders in Parkinson's disease and studies that need to be performed before clinical trials.

Pawlak CR, Chen FS, Wu FY, Ho YJ. Pawlak CR, et al. Kaohsiung J Med Sci. 2012 Aug;28(8):407-17. doi: 10.1016/j.kjms.2012.02.010. Epub 2012 Apr 22. Kaohsiung J Med Sci. 2012. PMID: 22892161 Free article. Review.

4

A phenotype-driven ENU mutagenesis screen for the identification of dominant mutations involved in alcohol consumption.

Pawlak CR, Sanchis-Segura C, Soewarto D, Wagner S, Hrabé de Angelis M, Spanagel R. Pawlak CR, et al. Mamm Genome. 2008 Feb;19(2):77-84. doi: 10.1007/s00335-007-9087-4. Epub 2008 Jan 23. Mamm Genome. 2008. PMID: 18213483

5

Repeated nicotine treatment in rats with high versus low rearing activity: analyses of behavioural sensitisation and place preference.

Pawlak CR, Schwarting RK. Pawlak CR, et al. Psychopharmacology (Berl). 2005 Apr;178(4):440-50. doi: 10.1007/s00213-004-2024-2. Epub 2004 Nov 17. Psychopharmacology (Berl). 2005. PMID: 15765259

6

Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.

Ho YJ, Ho SC, Pawlak CR, Yeh KY. Ho YJ, et al. Among authors: pawlak cr. Behav Brain Res. 2011 Jun 1;219(2):280-90. doi: 10.1016/j.bbr.2011.01.028. Epub 2011 Jan 22. Behav Brain Res. 2011. PMID: 21262271

7

Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model.

Hsieh MH, Ho SC, Yeh KY, Pawlak CR, Chang HM, Ho YJ, Lai TJ, Wu FY. Hsieh MH, et al. Among authors: pawlak cr. Pharmacol Biochem Behav. 2012 Jul;102(1):64-71. doi: 10.1016/j.pbb.2012.03.022. Epub 2012 Mar 31. Pharmacol Biochem Behav. 2012. PMID: 22487770

8

Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model.

Ho SC, Hsu CC, Pawlak CR, Tikhonova MA, Lai TJ, Amstislavskaya TG, Ho YJ. Ho SC, et al. Among authors: pawlak cr. Behav Brain Res. 2014 Jul 15;268:177-84. doi: 10.1016/j.bbr.2014.04.022. Epub 2014 Apr 19. Behav Brain Res. 2014. PMID: 24755306

9

Effects of D-cycloserine on the behavior and ERK activity in the amygdala: role of individual anxiety levels.

Wu SL, Hsu LS, Tu WT, Wang WF, Huang YT, Pawlak CR, Ho YJ. Wu SL, et al. Among authors: pawlak cr. Behav Brain Res. 2008 Mar 5;187(2):246-53. doi: 10.1016/j.bbr.2007.09.013. Epub 2007 Sep 16. Behav Brain Res. 2008. PMID: 17959260

10

Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats.

Wang AL, Liou YM, Pawlak CR, Ho YJ. Wang AL, et al. Among authors: pawlak cr. Behav Brain Res. 2010 Mar 17;208(1):38-46. doi: 10.1016/j.bbr.2009.11.006. Epub 2009 Nov 10. Behav Brain Res. 2010. PMID: 19900486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters